Prognostic Signature of Alternative Splicing Events in Bladder Urothelial Carcinoma Based on Spliceseq Data from 317 Cases

Background/Aims: Increasing evidences indicated the important roles of alternative splicing in the progression and prognosis of bladder urothelial carcinoma (BLCA). However, most previous research has focused on one or several alternative splicing events, without a comprehensive evaluation of the pr...

Full description

Bibliographic Details
Main Authors: Rong-quan He, Xian-guo Zhou, Qiao-yong Yi, Cai-wang Deng, Jia-min Gao, Gang Chen, Qiu-yan Wang
Format: Article
Language:English
Published: Cell Physiol Biochem Press GmbH & Co KG 2018-07-01
Series:Cellular Physiology and Biochemistry
Subjects:
Online Access:https://www.karger.com/Article/FullText/492094
_version_ 1818177319828717568
author Rong-quan He
Xian-guo Zhou
Qiao-yong Yi
Cai-wang Deng
Jia-min Gao
Gang Chen
Qiu-yan Wang
author_facet Rong-quan He
Xian-guo Zhou
Qiao-yong Yi
Cai-wang Deng
Jia-min Gao
Gang Chen
Qiu-yan Wang
author_sort Rong-quan He
collection DOAJ
description Background/Aims: Increasing evidences indicated the important roles of alternative splicing in the progression and prognosis of bladder urothelial carcinoma (BLCA). However, most previous research has focused on one or several alternative splicing events, without a comprehensive evaluation of the prognostic value of splicing events in BLCA. In this study, we aimed to determine risk scores for predicting prognosis of BLCA patients based on splicing events. Methods: RNA-sequencing data and clinical information of BLCA patients were downloaded from The Cancer Genome Atlas, and data of splicing events were obtained from the SpliceSeq database. Univariate and multivariate Cox regression analyses were employed to identify survival-associated alternative spicing events (SASEs) and to calculate risk scores. Protein-protein interaction analysis of genes of the SASEs was performed using STRING, a database of known and predicted protein-protein interactions, and pathway enrichment analysis of the genes was implemented using the Database for Annotation, Visualization and Integrated Discovery (version 6.8). Receiver operating characteristic (ROC) curves and Kaplan-Meier analysis were used to evaluate the clinical significance of genes from the SASEs for building a risk score in BLCA. Correlation between splicing events of splicing factors and non-splicing factors were analyzed with Pearson correlation coefficient. A potential regulatory network was then built using Cytoscape 3.5. Results: In total, 39,508 alternative splicing events in 317 patients with BLCA were analyzed, including 4,632 SASEs. The area under the curve of the ROC of risk score (all) was 0.748 for predicting survival status of BLCA patients. Low- and high-risk score groups classified using the median “risk score (all)” value displayed remarkably different survival time (Low vs. High = 3304.841±239.758 vs 1198.614±152.460 days). The potential regulatory network with SASEs of splicing factors and other genes was constructed, which might be part of the biological mechanisms associated with prognosis of BLCA patients. Conclusions: In this study, prognostic signatures constructed using splicing events could be used for predicting the prognosis of BLCA patients.
first_indexed 2024-12-11T20:30:12Z
format Article
id doaj.art-8417cd5c7d0b411ea0faa9ea77dc71b6
institution Directory Open Access Journal
issn 1015-8987
1421-9778
language English
last_indexed 2024-12-11T20:30:12Z
publishDate 2018-07-01
publisher Cell Physiol Biochem Press GmbH & Co KG
record_format Article
series Cellular Physiology and Biochemistry
spelling doaj.art-8417cd5c7d0b411ea0faa9ea77dc71b62022-12-22T00:51:51ZengCell Physiol Biochem Press GmbH & Co KGCellular Physiology and Biochemistry1015-89871421-97782018-07-014831355136810.1159/000492094492094Prognostic Signature of Alternative Splicing Events in Bladder Urothelial Carcinoma Based on Spliceseq Data from 317 CasesRong-quan HeXian-guo ZhouQiao-yong YiCai-wang DengJia-min GaoGang ChenQiu-yan WangBackground/Aims: Increasing evidences indicated the important roles of alternative splicing in the progression and prognosis of bladder urothelial carcinoma (BLCA). However, most previous research has focused on one or several alternative splicing events, without a comprehensive evaluation of the prognostic value of splicing events in BLCA. In this study, we aimed to determine risk scores for predicting prognosis of BLCA patients based on splicing events. Methods: RNA-sequencing data and clinical information of BLCA patients were downloaded from The Cancer Genome Atlas, and data of splicing events were obtained from the SpliceSeq database. Univariate and multivariate Cox regression analyses were employed to identify survival-associated alternative spicing events (SASEs) and to calculate risk scores. Protein-protein interaction analysis of genes of the SASEs was performed using STRING, a database of known and predicted protein-protein interactions, and pathway enrichment analysis of the genes was implemented using the Database for Annotation, Visualization and Integrated Discovery (version 6.8). Receiver operating characteristic (ROC) curves and Kaplan-Meier analysis were used to evaluate the clinical significance of genes from the SASEs for building a risk score in BLCA. Correlation between splicing events of splicing factors and non-splicing factors were analyzed with Pearson correlation coefficient. A potential regulatory network was then built using Cytoscape 3.5. Results: In total, 39,508 alternative splicing events in 317 patients with BLCA were analyzed, including 4,632 SASEs. The area under the curve of the ROC of risk score (all) was 0.748 for predicting survival status of BLCA patients. Low- and high-risk score groups classified using the median “risk score (all)” value displayed remarkably different survival time (Low vs. High = 3304.841±239.758 vs 1198.614±152.460 days). The potential regulatory network with SASEs of splicing factors and other genes was constructed, which might be part of the biological mechanisms associated with prognosis of BLCA patients. Conclusions: In this study, prognostic signatures constructed using splicing events could be used for predicting the prognosis of BLCA patients.https://www.karger.com/Article/FullText/492094Bladder urothelial carcinomaSplicing eventThe Cancer Genome Atlas (TCGA)Prognosis
spellingShingle Rong-quan He
Xian-guo Zhou
Qiao-yong Yi
Cai-wang Deng
Jia-min Gao
Gang Chen
Qiu-yan Wang
Prognostic Signature of Alternative Splicing Events in Bladder Urothelial Carcinoma Based on Spliceseq Data from 317 Cases
Cellular Physiology and Biochemistry
Bladder urothelial carcinoma
Splicing event
The Cancer Genome Atlas (TCGA)
Prognosis
title Prognostic Signature of Alternative Splicing Events in Bladder Urothelial Carcinoma Based on Spliceseq Data from 317 Cases
title_full Prognostic Signature of Alternative Splicing Events in Bladder Urothelial Carcinoma Based on Spliceseq Data from 317 Cases
title_fullStr Prognostic Signature of Alternative Splicing Events in Bladder Urothelial Carcinoma Based on Spliceseq Data from 317 Cases
title_full_unstemmed Prognostic Signature of Alternative Splicing Events in Bladder Urothelial Carcinoma Based on Spliceseq Data from 317 Cases
title_short Prognostic Signature of Alternative Splicing Events in Bladder Urothelial Carcinoma Based on Spliceseq Data from 317 Cases
title_sort prognostic signature of alternative splicing events in bladder urothelial carcinoma based on spliceseq data from 317 cases
topic Bladder urothelial carcinoma
Splicing event
The Cancer Genome Atlas (TCGA)
Prognosis
url https://www.karger.com/Article/FullText/492094
work_keys_str_mv AT rongquanhe prognosticsignatureofalternativesplicingeventsinbladderurothelialcarcinomabasedonspliceseqdatafrom317cases
AT xianguozhou prognosticsignatureofalternativesplicingeventsinbladderurothelialcarcinomabasedonspliceseqdatafrom317cases
AT qiaoyongyi prognosticsignatureofalternativesplicingeventsinbladderurothelialcarcinomabasedonspliceseqdatafrom317cases
AT caiwangdeng prognosticsignatureofalternativesplicingeventsinbladderurothelialcarcinomabasedonspliceseqdatafrom317cases
AT jiamingao prognosticsignatureofalternativesplicingeventsinbladderurothelialcarcinomabasedonspliceseqdatafrom317cases
AT gangchen prognosticsignatureofalternativesplicingeventsinbladderurothelialcarcinomabasedonspliceseqdatafrom317cases
AT qiuyanwang prognosticsignatureofalternativesplicingeventsinbladderurothelialcarcinomabasedonspliceseqdatafrom317cases